Try our Advanced Search for more refined results
Wehner v. Genentech, Inc. et al
Case Number:
3:20-cv-06894
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
January 11, 2024
Genentech 401(k) Fee Deal OK'd, Paving Way For Appeal
A California federal judge on Thursday gave preliminary approval to a $250,000 settlement to resolve allegations that Genentech overcharged employees for 401(k) recordkeeping fees, a deal that will allow the plaintiff to appeal a prior decision in the case tossing allegations that the retirement plan made bad investments.
-
November 22, 2023
Genentech, 30K-Strong Class Reach Deal In 401(k) Fee Suit
Genentech and a certified class of over 30,000 members have asked a California federal judge to approve a $250,000 settlement to resolve allegations the biotech company overcharged its employees for 401(k) recordkeeping fees, according to a motion for preliminary approval.
-
August 14, 2023
Genentech Denied Quick Exit In 'Uncertain' 401(k) Fees Suit
A California federal judge rejected Genentech's bid to get an early win in a certified class action alleging the biotech company overcharged its employees for 401(k) recordkeeping fees, saying although the suit's claims for breach of fiduciary duty "appear uncertain," the case should proceed to an October bench trial.
-
May 31, 2023
Genentech Urges End To 'Threadbare' 401(k) Fees Suit
Genentech urged a California federal judge to grant the biotechnology company an early win in a class action alleging it overcharged employees for 401(k) recordkeeping fees, saying there is "no need" for a bench trial on the "threadbare" allegations that are "totally exposed and ripe for summary judgment."
-
September 21, 2022
Genentech Agrees To 30K-Strong Class In 401(k) Fees Suit
Genentech and a former worker who accused the biotechnology company in a lawsuit of overcharging employees in 401(k) recordkeeping fees agreed to move the suit forward as a class, and asked a California federal judge to approve the action estimated to represent 30,000 members.
-
June 15, 2021
Genentech Can't Shake Ex-Worker's 401(k) Fee Suit
Genentech Inc. can't escape a proposed ERISA class action over 401(k) plan management, with a California federal judge trimming an allegation that the plan made bad investments from the suit but letting a claim that the plan charged excessive fees proceed.
-
February 10, 2021
Genentech Wins Toss Of Employee's 401(k) Suit
A California federal court on Tuesday axed a proposed class action claiming biotechnology company Genentech Inc. overcharged beneficiaries participating in its $7.6 billion 401(k) plan, ruling that the employee's comparisons to fees charged by other programs were too imprecise to hold water.